showed that higher serum BAFF levels were associated with hepatocyte ballooning and advanced fibrosis in these patients, concluding that serum BAFF levels may be a useful tool for distinguishing NASH from simple steatosis (96). Here, TNFSF13B is linked to metabolic dysfunction-associated steatohepatitis.